cholangiocellular

cholangiocellular

/cho·lan·gi·o·cel·lu·lar/ (-sel´u-lar) of, resembling, or pertaining to cells of the cholangioles.

cholangiocellular

pertaining to the bile ducts.

cholangiocellular adenoma
solid or cystic; may be neoplastic or congenital or acquired cystic lesions.
cholangiocellular carcinoma
multiple, firm, white tumors occurring usually in dogs and cats. Capsular lesions have a typical umbilication of their serosal surface. Metastatic spread is constant. Called also bile duct carcinoma.
cholangiocellular cystadenoma
a variety of bile duct adenoma in which the tumor is composed of multilocular cystic structures lined with epithelium resembling that of bile ducts.
References in periodicals archive ?
f) For liver tumors, updated classification used by QA and PWG pathologists and newer RI studies use hepatocellular adenoma/carcinoma descriptors, with those consisting of hepatocellular and cholangiocellular elements now being diagnosed as hepatocholangiomas or hepatocholangiocarcinomas.
Thus, we will consider benign liver tumors of epithelial and nonepithelial origin, with the epithelial tumors further classified into tumors of either cholangiocellular or hepatocellular origin.
Vitamin K2-induced cell growth inhibition via autophagy formation in cholangiocellular carcinoma cell lines.
Transforming growth factor [beta]1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells.
According to the results: -- The AMDL-ELISA DR-70 (FDP) test showed strong clinical performance with a sensitivity of 91% and a specificity of 93% in testing conducted on patients with hepatocellular, cholangiocellular, pancreatic, colorectal, stomach and oesophagus cancers.
Metastatic cholangiocellular carcinoma and renal adenocarcinoma in a golden eagle (Aquila chrysaetos).
Malignancies included 5 ovarian, 4 hepatoma, 3 colon, 3 mesothelioma, 2 gastric, 2 breast, 1 cholangiocellular, and 1 pancreatic carcinoma.
Subsequent abdominal US depicted a focal liver lesion, ~2 cm in diameter, which needle biopsy proved to be a well-differentiated hepatocellular carcinoma with cholangiocellular differentiation areas.
Global Markets Direct's, 'Cholangiocellular Hepatoma - Pipeline Review, H2 2012', provides an overview of the Cholangiocellular Hepatoma therapeutic pipeline.
It also reviews key players involved in the therapeutic development for Cholangiocellular Hepatoma.
A snapshot of the global therapeutic scenario for Cholangiocellular Hepatoma.
Primary liver cancer is classified into HCC and cholangiocellular carcinoma, and about 94% is HCC.